135 related articles for article (PubMed ID: 36274212)
1. Serum CHI3L1 as a Biomarker for Non-invasive Diagnosis of Liver Fibrosis.
Bao J; Ouyang Y; Qiao L; He J; Liu F; Wang Y; Miao L; Fu A; Lou Z; Zang Q; Huang W; Huang J; Li Z
Discov Med; 2022; 33(168):41-49. PubMed ID: 36274212
[TBL] [Abstract][Full Text] [Related]
2. Expression of chitinase-3-like protein 1 in different TCM syndromes and its correlation with liver fibrosis.
Li H; Xu X; Yi T; Zheng T; Yan T
Ann Palliat Med; 2022 Jan; 11(1):217-224. PubMed ID: 35144413
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of serum chitinase-3-like protein 1 in chronic liver disease of significant fibrosis and cirrhosis].
Li H; Yan T; Zhu Z; Bao ZW; Xu TM; Xie J; Zheng SQ; Cui MM; Liu LG
Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):337-341. PubMed ID: 29996200
[No Abstract] [Full Text] [Related]
4. CHI3L1 Is a Liver-Enriched, Noninvasive Biomarker That Can Be Used to Stage and Diagnose Substantial Hepatic Fibrosis.
Huang H; Wu T; Mao J; Fang Y; Zhang J; Wu L; Zheng S; Lin B; Pan H
OMICS; 2015 Jun; 19(6):339-45. PubMed ID: 26415140
[TBL] [Abstract][Full Text] [Related]
5. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
6. A noninvasive diagnostic model for significant liver fibrosis in patients with chronic hepatitis B based on CHI3L1 and routine clinical indicators.
Huang Q; Wu J; Huang C; Wang X; Xu Z
Ann Palliat Med; 2021 May; 10(5):5509-5519. PubMed ID: 34107703
[TBL] [Abstract][Full Text] [Related]
7. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
Cao X; Shang QH; Chi XL; Zhang W; Xiao HM; Sun MM; Chen G; An Y; Lv CL; Wang L; Nan YM; Chen CY; Tan ZN; Liu XE; Zhuang H
World J Gastroenterol; 2020 Mar; 26(10):1067-1079. PubMed ID: 32205997
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases.
Jiang Z; Wang S; Jin J; Ying S; Chen Z; Zhu D; Xiao B; Hu Y; Qian Y; Cai T; Fu L
J Clin Lab Anal; 2020 May; 34(5):e23200. PubMed ID: 31916309
[TBL] [Abstract][Full Text] [Related]
9. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China.
Jin X; Fu B; Wu ZJ; Zheng XQ; Hu JH; Jin LF; Tang LL
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):384-389. PubMed ID: 32540209
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Chitinase 3-like 1 (CHI3L1) as a noninvasive biomarker of hepatic fibrosis in patients with Hepatitis B virus-related compensated chronic liver disease.
Das A; Kamrul-Hasan A; Kabir MR; Das S; Zaki K; Al Mahtab M
J Family Med Prim Care; 2021 Apr; 10(4):1694-1698. PubMed ID: 34123914
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four markers of hepatic fibrosis and hepatic function indices in patients with liver cirrhosis and hepatoma.
Ma HY; Dong L; Quan SZ; Li RY; Wang XR
Ann Palliat Med; 2021 Apr; 10(4):4108-4121. PubMed ID: 33832299
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B core-related antigen serum levels are associated with significant liver fibrosis in treatment-naive chronic HBV infection patients.
Liu R; Li M; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hao H; Hu L; Gao Y; Xu M; Xie Y
J Viral Hepat; 2022 Jun; 29(6):438-446. PubMed ID: 35357759
[TBL] [Abstract][Full Text] [Related]
13. Chitinase 3-like 1 is a profibrogenic factor overexpressed in the aging liver and in patients with liver cirrhosis.
Nishimura N; De Battista D; McGivern DR; Engle RE; Tice A; Fares-Gusmao R; Kabat J; Pomerenke A; Nguyen H; Sato S; Bock KW; Moore IN; Kleiner DE; Zamboni F; Alter HJ; Govindarajan S; Farci P
Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33888584
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis.
Yang XZ; Gen AW; Xian JC; Xiao L
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):479-485. PubMed ID: 29424906
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
Yan L; Deng Y; Zhou J; Zhao H; Wang G;
Infection; 2018 Jun; 46(3):385-393. PubMed ID: 29600444
[TBL] [Abstract][Full Text] [Related]
16. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients.
Liu XD; Wu JL; Liang J; Zhang T; Sheng QS
World J Gastroenterol; 2012 Jun; 18(22):2784-92. PubMed ID: 22719186
[TBL] [Abstract][Full Text] [Related]
17. Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B.
Liu J; Ji Y; Ai H; Ning B; Zhao J; Zhang Y; Dun G
Korean J Radiol; 2016; 17(3):396-404. PubMed ID: 27134527
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of liver pathological characteristics and exploration of noninvasive markers of liver fibrosis in children with chronic hepatitis B].
Liang CF; Chang YN; Peng XR; He Y; Chen M; Peng ML; Hu P; Ren H; Xu HM
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):551-557. PubMed ID: 34225430
[No Abstract] [Full Text] [Related]
19. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
[TBL] [Abstract][Full Text] [Related]
20. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
